Jefferies Financial Group Comments on Tenet Healthcare Co.’s Q3 2022 Earnings (NYSE:THC)

Tenet Healthcare Co. (NYSE:THCGet Rating) – Equities research analysts at Jefferies Financial Group reduced their Q3 2022 earnings per share (EPS) estimates for shares of Tenet Healthcare in a research report issued on Wednesday, April 20th. Jefferies Financial Group analyst B. Tanquilut now forecasts that the company will post earnings of $1.48 per share for the quarter, down from their previous forecast of $1.82. Jefferies Financial Group currently has a “Buy” rating and a $125.00 target price on the stock. Jefferies Financial Group also issued estimates for Tenet Healthcare’s Q4 2022 earnings at $1.77 EPS.

Tenet Healthcare (NYSE:THCGet Rating) last announced its quarterly earnings results on Wednesday, April 20th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.04 by $0.89. Tenet Healthcare had a net margin of 4.92% and a return on equity of 51.84%. The firm had revenue of $4.75 billion during the quarter, compared to analysts’ expectations of $4.74 billion. During the same period in the prior year, the company earned $1.30 EPS. The firm’s revenue was down .8% on a year-over-year basis.

Other equities research analysts have also issued research reports about the stock. Raymond James upgraded shares of Tenet Healthcare from an “outperform” rating to a “strong-buy” rating and increased their price objective for the stock from $105.00 to $120.00 in a research note on Thursday, January 20th. StockNews.com upgraded shares of Tenet Healthcare from a “hold” rating to a “buy” rating in a research note on Friday. Barclays upped their target price on shares of Tenet Healthcare from $99.00 to $104.00 and gave the stock an “overweight” rating in a research report on Friday. Wells Fargo & Company began coverage on shares of Tenet Healthcare in a research report on Monday, March 28th. They issued an “overweight” rating and a $100.00 target price for the company. Finally, Mizuho increased their price objective on shares of Tenet Healthcare from $90.00 to $103.00 and gave the company a “buy” rating in a report on Thursday, March 3rd. Two research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $103.47.

THC opened at $73.11 on Monday. The firm has a market cap of $7.85 billion, a price-to-earnings ratio of 8.31, a price-to-earnings-growth ratio of 3.06 and a beta of 2.42. Tenet Healthcare has a fifty-two week low of $54.62 and a fifty-two week high of $92.65. The company’s 50-day moving average price is $85.74 and its 200 day moving average price is $78.71. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 7.16.

In other Tenet Healthcare news, Chairman Ronald A. Rittenmeyer sold 59,851 shares of the firm’s stock in a transaction on Wednesday, March 2nd. The shares were sold at an average price of $90.12, for a total value of $5,393,772.12. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Richard J. Mark sold 6,000 shares of the firm’s stock in a transaction on Wednesday, March 9th. The stock was sold at an average price of $90.47, for a total transaction of $542,820.00. The disclosure for this sale can be found here. 1.70% of the stock is owned by corporate insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Mackenzie Financial Corp lifted its holdings in shares of Tenet Healthcare by 7.4% during the 3rd quarter. Mackenzie Financial Corp now owns 37,241 shares of the company’s stock worth $2,474,000 after acquiring an additional 2,560 shares during the period. Schonfeld Strategic Advisors LLC lifted its holdings in shares of Tenet Healthcare by 37.2% during the 3rd quarter. Schonfeld Strategic Advisors LLC now owns 84,200 shares of the company’s stock worth $5,595,000 after acquiring an additional 22,835 shares during the period. Retirement Systems of Alabama lifted its holdings in shares of Tenet Healthcare by 1.2% during the 4th quarter. Retirement Systems of Alabama now owns 140,279 shares of the company’s stock worth $11,459,000 after acquiring an additional 1,665 shares during the period. Victory Capital Management Inc. lifted its holdings in Tenet Healthcare by 5.5% during the 3rd quarter. Victory Capital Management Inc. now owns 498,709 shares of the company’s stock valued at $33,134,000 after purchasing an additional 26,194 shares during the last quarter. Finally, USA Financial Portformulas Corp bought a new position in Tenet Healthcare during the 3rd quarter valued at about $142,000. Institutional investors own 94.38% of the company’s stock.

Tenet Healthcare Company Profile (Get Rating)

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Recommended Stories

Earnings History and Estimates for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.